Stay updated on Pimavanserin in Impulse Control Disorders Clinical Trial
Sign up to get notified when there's something new on the Pimavanserin in Impulse Control Disorders Clinical Trial page.

Latest updates to the Pimavanserin in Impulse Control Disorders Clinical Trial page
- Check7 days agoChange DetectedThe page history shows an addition of Revision: v3.3.3 and deletions of HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer area. These are site-wide updates and do not affect the study record, data, or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedAdded revision v3.3.2 to the record history and removed revision v3.2.0.SummaryDifference0.1%

- Check42 days agoChange DetectedThe temporary government funding/operating-status notice at the top of the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check57 days agoChange DetectedThe history shows multiple version updates adding and revising study status, recruitment status, and contacts/locations, with later versions also introducing the IPDSharing field.SummaryDifference0.1%

- Check86 days agoChange DetectedUpdated version to v3.2.0 and added a government-operating-status notice; removed the prior v3.1.0 tag.SummaryDifference12%

- Check94 days agoChange DetectedVersion update from v3.0.2 to v3.1.0, indicating a new release but no other substantive content changes.SummaryDifference0.3%

Stay in the know with updates to Pimavanserin in Impulse Control Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pimavanserin in Impulse Control Disorders Clinical Trial page.